A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Developers of Alzheimer’s drugs have work cut out for them getting the treatments to patients.
ShareListen(2 min)